Spark Investment Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Spark Investment Management’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-20,900	Closed	-$243K	–	571
2019 Q3	$243K	Sell	20,900 -11,307	-35%	-$140K	0.03%	311
2019 Q2	$483K	Hold	32,207	–	–	0.03%	374
2019 Q1	$564K	Buy	+32,207	New	+$508K	0.03%	399
2018 Q3	–	Sell	-59,900	Closed	-$1.18M	–	723
2018 Q2	$1.18M	Buy	+59,900	New	+$1.13M	0.07%	334
2015 Q2	–	Sell	-25,025	Closed	-$533K	–	720
2015 Q1	$533K	Buy	+25,025	New	+$587K	0.07%	357

Other funds holding RCKT

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Spark Investment Management's RCKT Position: Q4 2019 in Review

Spark Investment Management sold out of Rocket Pharmaceuticals (RCKT) in Q4 2019, closing a stake of 20,900 shares — an estimated $243K sold.

Spark Investment Management first reported a position in RCKT in Q1 2015 and held it in 5 quarters. The position peaked at $1.18M in Q2 2018. 120 funds tracked by Wall St. Rank hold RCKT as of Q4 2019.

Spark Investment Management reported no remaining Rocket Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
Spark Investment Management sold 20,900 Rocket Pharmaceuticals shares in Q4 2019, an estimated $243K.
Spark Investment Management first reported a position in Rocket Pharmaceuticals in Q1 2015 and held it in 5 quarters.
Spark Investment Management's Rocket Pharmaceuticals position peaked at $1.18M in Q2 2018.
120 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q4 2019.

Based on Spark Investment Management's 13F filing for Q4 2019, filed 11 Feb 2020.